Join
Live feed
·
INSIDERFilingvia Quantisnow
Ultragenyx Pharmaceutical Inc. logo

EVP and Chief Legal Officer Parschauer Karah Herdman was granted 18,443 shares and sold $540,817 worth of shares (12,846 units at $42.10), increasing direct ownership by 8% to 75,287 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RARE (Ultragenyx Pharmaceutical Inc.) and more on Quantisnow.